Immunochemotherapy for non-Hodgkin lymphoma
Immunochemotherapy (also called chemoimmunotherapy) combines two powerful treatments: immunotherapy and chemotherapy. Cancer immunotherapy is the use of certain agents that stimulate the immune system to attack and destroy cancer cells. Chemotherapy is the use of drugs designed to destroy or slow the growth of cancer cells.
A common immunochemotherapy regimen for non-Hodgkin lymphoma is CHOP-R, which is a combination of the CHOP chemotherapy regime and the monoclonal antibody rituximab.
Immunochemotherapy may temporarily lower your blood cell counts, causing various side effects. For example, anemia (low red blood cell count) can cause fatigue and shortness of breath. In addition, neutropenia (low white blood cell count) can make you more susceptible to infection.
Your non-Hodgkin lymphoma care team anticipates and proactively manages the potential side effects of immunochemotherapy. Throughout your treatment, we’ll do routine blood tests and, if necessary, provide certain drugs or modify your treatment regime to help restore your blood counts to normal levels.
You will also receive various supportive care services, such as nutrition therapy, naturopathic medicine, pain management, oncology rehabilitation and mind-body medicine. These therapies are designed to keep you strong and nutritionally fortified, reduce side effects and increase your sense of well-being throughout your non-Hodgkin lymphoma treatment.